Abstract: The present invention relates to solid state forms of oclacitinib maleate and methods for the preparation of the solid state forms of oclacitinib maleate. The solid state forms of oclacitinib maleate of the present invention include amorphous oclacitinib maleate, crystalline tetramethyl urea solvate form of oclacitinib maleate, crystalline monohydrate form of oclacitinib maleate and crystalline form of oclacitinib maleate (form B).
Type:
Grant
Filed:
January 29, 2020
Date of Patent:
January 21, 2025
Assignee:
VationPharma B.V.
Inventors:
Bin Li, Analia Ivanna Chamorro Orue, Anna Katharina Mellor